Neurodegenerative disease research coordination
4 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- MINISTRY OF HEALTH
Israel's national health authority coordinating transnational research funding in rare diseases, AMR, neuroscience, and personalized medicine through ERA-NET mechanisms.
“Participated in JPco-fuND, JPCOFUND2, and both NEURON Cofund iterations, supporting the JPND strategic research agenda.”
IL22 projects - SYNAPSE RESEARCH MANAGEMENT PARTNERS SL
Spanish SME managing operations, data governance, and sustainability for Europe's largest public-private health research consortia.
“Coordinated NEURONET (IMI neurodegeneration portfolio management), participated in AMYPAD and ROADMAP (Alzheimer's), and EPND (neurodegenerative biomarkers platform).”
PrimarySMEES17 projects - SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET
Croatian medical faculty with regenerative medicine clinical trial expertise and a growing role in EU-13 health research capacity building.
“Contributed to JPsustaiND, supporting the Joint Programming Initiative on Neurodegenerative Diseases including Alzheimer's research agenda alignment.”
HR10 projects - NEUROIMUNOLOGICKY USTAV SLOVENSKEJAKADEMIA VIED
Slovak neuroimmunology institute specialising in tau protein structural biology (NMR, cryo-EM) for Alzheimer's disease research.
“JPsustaiND (2015–2021) involved mapping and aligning national research agendas for the JPND Joint Programming Initiative covering Alzheimer's and other neurodegenerative diseases.”
SK2 projects